Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter"

Transcription

1 Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

2 Endoskopische Venenentnahme (EVH) - Einführung 1979 Tevaearai und Kollegen haben als erstes die MIVH Technik bei 30 Patienten durchgeführt unter Verwendung des MiniHarvest System (US Surgical Corporation, Norwalk, Conn) 1996 Lumsden und Kollegen haben als erstes die EVH bei 30 Patienten durchgeführt und beschrieben (Georgia, USA) 1.Tevaearai HT et al. Minimally invasive harvest of the saphenous vein for coronary artery bypass grafting. Ann Thorac Surg. 1997;63(6): Lumsden AB et al. Subcutaneous, veideo-assisted saphenous vein harvest: report of the first 30 cases. Cardiovasc Surg. 1996; 4(6): 771-6

3 EVH Einsatz und Verbreitung in den USA 1 90% 92% 93% 0,8 0,6 65% 70% 76% 55% 82% 62% 71% 73% 76% 46% 0,4 0,2 0 2% 7% 15% 20% 28% 36% * E USER ADOPTION (% of hospitals using EVH) PENETRATION (% of CABG cases using EVH)

4 EVH in den USA und Europa

5 EVH Vorteile vs. OVH Geringeres chirurgisches Trauma Inzisionslänge, Blutverlust, Schmerzen, postoperative Immunfunktion schnellere Rekonvaleszenz geringere postop. Wundheilungsstörungen befriedigenderes kosmetisches Ergebnis (Kostenreduktion) Patientenzufriedenheit

6 EVH vs. OVH Kosmetisches Resultat offen endoskopisch

7 EVH vs. OVH Wundheilung 2-25%

8 EVH Patientenauswahl Keine Adipositas permagna Keine extrem oberflächliche Vena saphena Keine Seitenastvarikosis Keine Gerinnungsauffälligkeiten Keine Notfälle Nur selektiertes Patientengut

9 EVH Nachteile vs. OVH Bypass-Versagen Fehlende Langzeitergebnisse Längere Operationszeiten Kostenerhöhung

10 EVH vs. OVH aktuelle Datenlage Endoscopic Vascular Harvest in Coronary Artery Bypass Grafting Surgery: A Meta-Analysis of Randomized Trials and Controlled Trials Innovations 2005 Objective: EVH improves clinical and resource outcomes compared with OVH in adults undergoing CABG Methods: Comprehensive literature search (Medline, Embase ) to identify all randomized and nonrandomized trials of EVH vs. OVH up to April 2005 Primary outcome: wound complications Secondary outrcomes: any other clinical morbidity and resource utilization Results: 36 trials of patients 13 randomized (1.319 patients) 23 nonrandomized (8.313 patients) 3. Allen K, Cheng D, Cohn W, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Graft Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery Innovations. 2005; 1:51-60.

11 EVH vs. OVH aktuelle Datenlage Endoscopic Vascular Harvest in Coronary Artery Bypass Grafting Surgery: A Meta-Analysis of Randomized Trials and Controlled Trials Innovations 2005 Results: Risk of wound complications Risk of wound infections Need for surgical wound intervention significantly reduced by EVH vs. OVH Incidence of pain, neurolgia, patient satisfaction improved with EVH vs. OVH Postop. MI, stroke, reintervention, AP quality of graft not significantly different betw. EVH vs. OVH Operative time significantly increased by EVH 3. Allen K, Cheng D, Cohn W, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Graft Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery Innovations. 2005; 1:51-60.

12 EVH vs. OVH aktuelle Datenlage 2005 The International Society for Minimally Invasive Cardiac Surgery (ISMICS) Consensus Conference suggest: Innovations 2005 EVH is recommended to reduce wound related complications, improve patient satisfaction, and decrease postop. pain, hospital LOS, and outpatient wound management resources when compared to OVH (Class I; Level A) Based on quality of conduit harvested, either EVH or OVH technique may be used (Class IIa; Level B) Based on major adverse cardiac events and angiographic patency at 6 months, either EVH or OVH technique may be used (Class IIa; Level A) Conclusion: EVH should be considered the standard of care for patients who require saphenous vein grafts for coronary bypass surgery 3. Allen K, Cheng D, Cohn W, et al. Endoscopic Vascular Harvest in Coronary Artery Bypass Graft Surgery: A Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery Innovations. 2005; 1:51-60.

13 EVH vs. OVH aktuelle Datenlage Endoscopic versus Open Vein-Graft Harvesting in Coronary-Artery Bypass Surgery N Engl J Med 2009 Objective: Effect of EVH on vein-graft failure as assessed by angiography 12 to 18 months and on long-term clinical outcomes Methods: patients undergoing CABG (1.753 EVH; 1247 OVH); randomized, 107 centers Primary outcome: vein-graft failure (defined as >75% stenosis of graft on angio.) Clinical outcomes: death, MI, repeat revascularization (3 year follow-up period) Results: EVH significantly higher rates of vein-graft failure at 12 to 18 months than OVH (46.7% vs. 38.0%, P<0.001) EVH associated with higher rates of death, MI, or repeat revascularization after 3 y (20.2% vs. 17.4%, P=0.04) A 4. Lopes RD, Hafley GE, Allen KB et al. Endoscopic versus Open Vein-Graft Harvesting in Coronary-Artery Bypass Surgery: N Engl J Med. 2009; 361(3):

14 EVH vs. OVH aktuelle Datenlage Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting Objective: Assess the effect of EVH on short-term and midterm outcomes after CABG Ann Thorac Surg 2010 Methods: at a single center (Canada); data prospectively collected patients undergoing first time isolated CABG and combined valve/cabg (34.4%) patients EVH; (65.6%) patients OVH (continuous/bridging) Short-term outcomes: Midterm outcomes: leg infections, in-hospital mortality, all-cause mortality, readmission to hospital for cardiac catheterization, repeat revascularization, unstable angina, MI, heart failure median follow-up 2.6 years 5. Ouzounian M et al. Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting: Ann Thorac Surg. 2010; 89(2): A

15 EVH vs. OVH aktuelle Datenlage Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting Ann Thorac Surg 2010 Results: EVH associated with reduced rates of leg infection (1.1% vs. 2.2%, p=0.003) EVH similar rates of in-hospital mortality compared with OVH (3.2% vs. 4.0%, p=0.16) EVH no association with midterm adverse outcomes (hazard ratio 0.93, p=0.22) EVH and OVH similar freedom from death or readmission to hospital for cardiac cause EVH associated with reduced rate of readmission to hospital for unstable angina (hazard ratio 0.74), but not for MI Conclusion: EVH is not an independent predictor of in-hospital or midterm adverse outcomes 5. Ouzounian M et al. Impact of endoscopic versus open saphenous vein harvest techniques on outcomes after coronary artery bypass grafting: Ann Thorac Surg. 2010; 89(2): 403-8

16 A EVH vs. OVH aktuelle Datenlage Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Objective: Explore use of EVH and influence on perioperative and long-term outcomes Circulation 2011 Methods: at a 8 centers (north. New Engl.); data prospectively collected patients undergoing first time isolated CABG (excluded: <30y, emergency surgery, life-threatening malignancy, TAR, radial artery) (52.5%) patients EVH; (47.5%) patients OVH (continuous incision) Short-term outcomes: Long-term outcomes: in-hospital morbidity and mortality mortality and repeat revascularization (CABG or PCI) follow-up 4 years 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2):

17 EVH vs. OVH aktuelle Datenlage Results: Long-term outcome: Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Circulation 2011 mortality Figure 1. Adjusted risk of mortality by vein harvesting approach (2001 to 2004). The HR is for EVH relative to OVH related to mortality. Adjusted for age, sex, EF, vascular disease, DM, BMI 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2):

18 EVH vs. OVH aktuelle Datenlage Results: Long-term outcome: Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Circulation 2011 repeat revascularization Figure 2. Adjusted risk of repeat revasculariztaion by vein harvesting approach (2001 to 2004). The HR is for EVH relative to OVH related to risk of repeat revascularization. Adjusted for age, sex, EF, vascular disease, DM, BMI, 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2):

19 EVH vs. OVH aktuelle Datenlage Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting Circulation 2011 Results: In-Hospital outcomes: Use of OVH associated with an increased postop. leg wound infection (P<0.001) EVH associated with an increase in return to operating room for bleeding (P=0.03) Long-Term outcomes: EVH significantly associated with a reduced risk of mortality EVH associated with an insignificant increased risk of repeat revascularization Conclusion: EVH is a safe and viable technique for obtaining saphenous vein conduit for CABG Additional studies are warranted to improve understanding of mechanism by which EVH influences long-term outcomes, as well as how clinical teams can maximize the utility of this technique 6. Dacey LJ et al. Long-Term Outcomes of Endoscopic Vein Harvesting After Coronary Artery Bypass Grafting: Circulation. 2011; 123(2):

20 EVH - Schlussfolgerung Sicheres und praktikables Verfahren Datenlage zeigt durchweg geringere Wundkomplikationsraten Sehr gutes kosmetisches Ergebnis erhöhte Patientenzufriedenheit Prospektiv-randomisierte Studien Langzeitergebnisse nach EVH (EVH vs. MIVH) Kostenanalyse

Impact of Endoscopic Versus Open Saphenous Vein Harvest Techniques on Outcomes After Coronary Artery Bypass Grafting

Impact of Endoscopic Versus Open Saphenous Vein Harvest Techniques on Outcomes After Coronary Artery Bypass Grafting SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS member or an individual

More information

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium Background 8 th Coronary Physiology in the CathLab Course Revascularisation of intermediate stenosis can be targeted EITHER

More information

Endoscopic vs open saphenous vein harvest for coronary artery bypass grafting: A leg-related morbidity and histological comparison

Endoscopic vs open saphenous vein harvest for coronary artery bypass grafting: A leg-related morbidity and histological comparison Endoscopic vs open saphenous vein harvest for coronary artery bypass grafting: A leg-related morbidity and histological comparison Radim Brat a, Jaroslav Horacek b, Jiri Sieja a Aims. The aim of this study

More information

Treatment of Diabetic Patient with Multivessel Coronary Artery Disease: the Surgeon Perspective

Treatment of Diabetic Patient with Multivessel Coronary Artery Disease: the Surgeon Perspective Treatment of Diabetic Patient with Multivessel Coronary Artery Disease: the Surgeon Perspective Fabio B. Jatene Full Professor of Cardiovascular Surgery Heart Institute - HC-FMUSP fabiojatene@incor.usp.br

More information

aka EVH, Endo-vein, Endoscopic vessel harvesting Lisa Sand, PA-C

aka EVH, Endo-vein, Endoscopic vessel harvesting Lisa Sand, PA-C aka EVH, Endo-vein, Endoscopic vessel harvesting Lisa Sand, PA-C Objectives: Understand the importance of preoperative lower extremity evaluation Ultrasound imaging to determine satisfactory venous conduit

More information

Thoracic and Cardiac Surgery Volume. Other Cleveland Clinic hospitals Main campus. Surgical Procedure Volume by Type and Location (N = 13,714)

Thoracic and Cardiac Surgery Volume. Other Cleveland Clinic hospitals Main campus. Surgical Procedure Volume by Type and Location (N = 13,714) Surgical Overview Thoracic and Cardiac Surgery 7% Reoperations accounted for 7% of all cardiac surgeries performed at s main campus in. Reoperations are more complex and are associated with greater risk

More information

Endoscopic versus Open Saphenous Vein Harvest in Patients Undergoing CABG, an Angiographically Measured Graft Patency Comparison

Endoscopic versus Open Saphenous Vein Harvest in Patients Undergoing CABG, an Angiographically Measured Graft Patency Comparison Pacific University CommonKnowledge School of Physician Assistant Studies Theses, Dissertations and Capstone Projects 8-14-2010 Endoscopic versus Open Saphenous Vein Harvest in Patients Undergoing CABG,

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

Postoperative Myocardial Infarction: Diagnosis and Management

Postoperative Myocardial Infarction: Diagnosis and Management Postoperative Myocardial Infarction: Diagnosis and Management Todd M. Brown, MD, MSPH Chief Fellow Division of Cardiovascular Diseases December 9, 2008 CHEST PAIN NON-ANGINAL UNSURE ANGINAL STABLE ANGINA

More information

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Listen to your heart: Good Cardiovascular Health for Life

Listen to your heart: Good Cardiovascular Health for Life Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular

More information

Care of the Post-Cardiac Surgery Patient. Lundy J. Campbell, M.D. Associate Professor University of California

Care of the Post-Cardiac Surgery Patient. Lundy J. Campbell, M.D. Associate Professor University of California Care of the Post-Cardiac Surgery Patient Lundy J. Campbell, M.D. Associate Professor University of California Post-Operative Issues Post-op atrial fibrillation Acute kidney injury Acute respiratory failure

More information

Valve Disease. Valve Surgery Volume, Volume (N = 2798)

Valve Disease. Valve Surgery Volume, Volume (N = 2798) Valve Disease Valve Surgery, 1 1 1 (N = 79) 3 In 1, surgeons performed 79 valve surgeries. A total of 17 were primary operations and were reoperations. 1 1 11 1 13 1 surgeons have implanted more than 1,5

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Last Updated: Version 3.2 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Measure Set: Surgical Care Improvement Project (SCIP) Set Measure ID #: SCIP- Performance

More information

HA Territory-wide PCI Audit 2003-05

HA Territory-wide PCI Audit 2003-05 HA Territory-wide PCI Audit 23-5 5 PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 26 Percutaneous Coronary Intervention Background HA AP target 2/3, coordinated by PCI Working

More information

Multivessel Coronary Artery Disease: Bypass Surgery. Bruce Lytle, MD

Multivessel Coronary Artery Disease: Bypass Surgery. Bruce Lytle, MD Multivessel Coronary Artery Disease: Bypass Surgery Bruce Lytle, MD Coronary Artery Bypass Surgery Prolongs Survival Angiographic Subgroups MR (%) LMT stenosis (> 50%) 68% 3V CAD (> 50%) 42% 1/2V CAD and

More information

Denominator Statement: Cardiac surgery patients with no evidence of prior infection.

Denominator Statement: Cardiac surgery patients with no evidence of prior infection. Last Updated: Version 4.3b NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form CMS/The Joint Commission: Suspended (Effective immediately beginning with July 1, 2014 discharges)

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY (DAPT) Dual antiplatelet regimen

More information

Health Economic Evaluations of Endoscopic Vein Harvesting Compared to Open Vein Harvesting for Coronary Artery Bypass Grafting

Health Economic Evaluations of Endoscopic Vein Harvesting Compared to Open Vein Harvesting for Coronary Artery Bypass Grafting Medicine with Industrial Specialization Medical Market Access Aalborg University Fall 2011 Health Economic Evaluations of Endoscopic Vein Harvesting Compared to Open Vein Harvesting for Coronary Artery

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

The Bioresorbable Vascular Stent Dr Albert Ko

The Bioresorbable Vascular Stent Dr Albert Ko The Bioresorbable Vascular Stent Dr Albert Ko Dr Albert Ko MB BS, FRACP, FCSANZ Interventional/General Cardiologist Ascot Cardiology Symposium 2013 Treatment Goals for Coronary Artery Disease Relieve of

More information

2014 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)

2014 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) 2014 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) Physician Name: Patient Name: Last First MI Date of Birth: / / mm

More information

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013 Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation Michael Acker, MD For the CTSN Investigators AHA November 2013 Acknowledgements Supported by U01 HL088942 Cardiothoracic

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Medical technology guidance SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Medical technology guidance SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Medical technology guidance SCOPE The VeriQ system for assessing graft flow during coronary artery bypass graft surgery 1 Technology 1.1 Description

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

Myth Busters: Does Coronary Artery Bypass Grafting Impact Progression of Native Coronary Artery Disease?

Myth Busters: Does Coronary Artery Bypass Grafting Impact Progression of Native Coronary Artery Disease? Myth Busters: Does Coronary Artery Bypass Grafting Impact Progression of Native Coronary Artery Disease? Bobby Yanagawa MD PhD FRCSC Division of Cardiac Surgery St Michael s Hospital Shifting Our Attention

More information

Declaratory Ruling 2005-1 Replaces Declaratory Ruling 97-2

Declaratory Ruling 2005-1 Replaces Declaratory Ruling 97-2 Declaratory Ruling 2005-1 Replaces Declaratory Ruling 97-2 RE: The permitted role of unlicensed surgical assistants ( assistants ) in taking of the saphenous vein during coronary artery bypass graft (

More information

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient?

Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? Is Stenting or Coronary Artery By-pass Grafting the Better Treatment for This Patient? --- NIRS-IVUS TVC Imaging Adds Additional Information for the Heart Team Dr. Luis Tami Memorial Regional Hospital

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

The descriptive analysis of Endoscopic versus Traditional Open Vein Harvest. Technique for Coronary Artery Bypass Graft Surgery: report of 1974 Cases

The descriptive analysis of Endoscopic versus Traditional Open Vein Harvest. Technique for Coronary Artery Bypass Graft Surgery: report of 1974 Cases The descriptive analysis of Endoscopic versus Traditional Open Vein Harvest Technique for Coronary Artery Bypass Graft Surgery: report of 1974 Cases Authors: Mohammad Hassan NEZAFATI, MD (1) Pouya NEZAFATI

More information

The impact of the degree competitive flow on bypass graft occlusion.

The impact of the degree competitive flow on bypass graft occlusion. The impact of the degree competitive flow on bypass graft occlusion. Poster No.: C-2651 Congress: ECR 2013 Type: Authors: Keywords: Scientific Exhibit I. Menkov, I. Zheleznyak, S. Rud, G. E. Trufanov;

More information

The VeriQ system for assessing graft flow during coronary artery bypass graft surgery

The VeriQ system for assessing graft flow during coronary artery bypass graft surgery The VeriQ system for assessing graft flow during coronary artery bypass graft surgery Implementing NICE guidance November 2011 NICE medical technology guidance 8 What this presentation covers Background

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis Michael A. Blazing Outline The coming crush A practical approach to clinical risk assessment Classic approach to

More information

THE SOCIETY OF THORACIC SURGEONS

THE SOCIETY OF THORACIC SURGEONS THE SOCIETY OF THORACIC SURGEONS 633 N Saint Clair St, Floor 23 Chicago, IL 60611-3658 (312) 202-5800 sts@sts.org www.sts.org December 19, 2014 Cristie Upshaw Travis, Chair Lee Fleisher, MD, Vice Chair

More information

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor

More information

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction 3 year follow-up of the randomised trial Peter Clemmensen, Henning Kelbæk,

More information

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute

Dual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute Dual Antiplatelet Therapy Stephen Monroe, MD FACC Chattanooga Heart Institute Scope of Talk Identify the antiplatelet drugs and their mechanisms of action Review dual antiplatelet therapy in: The medical

More information

The return of myocardial ischemia after coronary artery

The return of myocardial ischemia after coronary artery Occurrence and Risk Factors for Reintervention After Coronary Artery Bypass Grafting Joseph F. Sabik III, MD; Eugene H. Blackstone, MD; A. Marc Gillinov, MD; Nicholas G. Smedira, MD; Bruce W. Lytle, MD

More information

Clinical Practice Assessment Robotic surgery

Clinical Practice Assessment Robotic surgery Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through

More information

Statins: Can there be too much of a good thing?

Statins: Can there be too much of a good thing? Statins: Can there be too much of a good thing? Spoiler alert No Oh Contraire Haaaaiiiiiiile No! Frequently under prescribing statin therapy! Typical Case 68 YO Smoker ACS Multiple prior PCI s Multiple

More information

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial

Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Apixaban Plus Mono vs. Dual Antiplatelet Therapy in Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial Connie N. Hess, MD, MHS, Stefan James, MD, PhD, Renato D. Lopes, MD, PhD, Daniel M. Wojdyla,

More information

When Are Prosthetic Grafts As Good As Veins?

When Are Prosthetic Grafts As Good As Veins? When Are Prosthetic Grafts As Good As Veins? Vascular Study Group of New England Jack L. Cronenwett, M.D. Dartmouth-Hitchcock Medical Center Disclosure I do not have any potential conflicts of interest.

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

8-9-2012. In hospital diabetes care background and challenges. Duality of interest. One of the goals may be...

8-9-2012. In hospital diabetes care background and challenges. Duality of interest. One of the goals may be... In hospital diabetes care background and challenges Duality of interest Nothing to disclose within the framework of this presentation My own fasting BG is 4.6 mmol/l, HbA1c 5.4% Bruce H.R. Wolffenbuttel

More information

Surgical Mitral Valve Repair The Gold Standard. A. Marc Gillinov, M.D.

Surgical Mitral Valve Repair The Gold Standard. A. Marc Gillinov, M.D. Surgical Mitral Valve Repair The Gold Standard A. Marc Gillinov, M.D. Disclosures Speaker/consultant Edwards Lifesciences Onyx Lifesciences Research support St. Jude Medical Medtronic A Common Case A Common

More information

Does the heart have to be stopped to do a Maze procedure?

Does the heart have to be stopped to do a Maze procedure? What are the surgical options to treat atrial fibrillation? New concepts for the surgical treatment of atrial fibrillation were introduced in recent years when the surgical device industry introduced different

More information

Antonio Colombo MD on behalf of the SECURITY Investigators

Antonio Colombo MD on behalf of the SECURITY Investigators Second Generation Drug-Eluting Stents Implantation Followed by Six Versus Twelve-Month - Dual Antiplatelet Therapy - The SECURITY Randomized Clinical Trial Antonio Colombo MD on behalf of the SECURITY

More information

CARDIAC RISKS OF NON CARDIAC SURGERY

CARDIAC RISKS OF NON CARDIAC SURGERY CARDIAC RISKS OF NON CARDIAC SURGERY N E W S T U D I E S & N E W G U I D E L I N E S W. B. C A L H O U N, M D, F A C C 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management

More information

Thrombolysis, thromboaspiration, ultrasound thrombectomy: adjuncts techniques for aorto-iliac recanalization.

Thrombolysis, thromboaspiration, ultrasound thrombectomy: adjuncts techniques for aorto-iliac recanalization. Thrombolysis, thromboaspiration, ultrasound thrombectomy: adjuncts techniques for aorto-iliac recanalization. Dr. S. Schepers Dr. F. Van Elst Sint-Trudo Hospital Sint-Truiden Belgium Chronic aorto-iliac

More information

06 Validation of risk prediction model

06 Validation of risk prediction model HA Territory-wide PCI Audit 2003-06 06 Validation of risk prediction model PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 2007 Background Participants: All HA hospitals via

More information

Endoscopic Vessel Harvesting: Using Advancements and Best Practices To Enhance Conduit Quality

Endoscopic Vessel Harvesting: Using Advancements and Best Practices To Enhance Conduit Quality Endoscopic Vessel Harvesting: Using Advancements and Best Practices To Enhance Conduit Quality Bershinsky, J Matt, PA-C; Bitondo, Jerene M, PA-C; Brennan, Teresa, PA-C, MPAS; Causey, Keith, PA-C; DeMara,

More information

VASCULAR SURGERY. 4. Assess the vascular system by appropriate skills in history-taking and in clinical examination.

VASCULAR SURGERY. 4. Assess the vascular system by appropriate skills in history-taking and in clinical examination. VASCULAR SURGERY PGY-1 Medical Knowledge 1. Describe human arterial and venous anatomy. 2. Describe basic arterial and venous hemodynamics. 3. Review the basic clinical manifestations of vascular disorders.

More information

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease What is Cardiac Rehabilitation? Cardiac rehabilitation is a comprehensive exercise, education, and behavior modification

More information

University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial

University of Ulsan College of Medicine, Asan Medical Center on behalf of the REAL-LATE and the ZEST-LATE trial Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Pooled Analysis of the REAL-LATE and the ZEST-LATE Trial Seung-Jung Park MD PhD Seung-Jung Park, MD, PhD, University of Ulsan

More information

Facing Coronary Artery Bypass Surgery? Learn about minimally invasive da Vinci Surgery

Facing Coronary Artery Bypass Surgery? Learn about minimally invasive da Vinci Surgery Facing Coronary Artery Bypass Surgery? Learn about minimally invasive da Vinci Surgery The Condition: Coronary Artery Disease Coronary artery disease is a form of heart disease that affects your arteries.

More information

Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes

Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes Kawasaki Disease Complicated by Coronary Artery Aneurysms: Mortality and 40-year Outcomes C. Manlhiot, A. Crean, N. Fernandopulle, B. Lew, N. Chahal, B.W. McCrindle Division of Cardiology, Department of

More information

Surgeons Role in Atrial Fibrillation

Surgeons Role in Atrial Fibrillation Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)

More information

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 87 of 593

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 87 of 593 Measure #40 (NQF 0048): Osteoporosis: Management Following Fracture of Hip, Spine or Distal Radius for Men and Women Aged 50 Years and Older National Quality Strategy Domain: Effective Clinical Care 2015

More information

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris Pros and cons of registers Prospective randomised trials constitute the cornerstone of "evidence-based" medicine, and they therefore

More information

Pre-Operative Cardiac Evaluation Kalpana Jain, MD

Pre-Operative Cardiac Evaluation Kalpana Jain, MD Pre-Operative Cardiac Evaluation Kalpana Jain, MD Cardiac evaluation is an integral part of pre-op evaluation. Perioperative cardiac events are common causes of mortality. Major cardiac complications associated

More information

Description of problem Description of proposed amendment Justification for amendment ERG response

Description of problem Description of proposed amendment Justification for amendment ERG response KEY INACCURACIES Issue 1 Distinguishing between groups of STEMI patients Key issue throughout the report The ERG distinguishes between groups of STEMI patients defining four patient groups: STEMI without

More information

Heart Surgery Ratings Background and Methodology August 2011

Heart Surgery Ratings Background and Methodology August 2011 Heart Surgery Ratings Background and Methodology August 2011 Background The Society of Thoracic Surgeons (STS) is a not-for-profit organization representing more than 6,000 surgeons, researchers, and allied

More information

PHYSICIAN ASSISTANTS IN CARDIAC SURGERY

PHYSICIAN ASSISTANTS IN CARDIAC SURGERY PHYSICIAN ASSISTANTS IN CARDIAC SURGERY Past,, and Future PAST 1965 first class of Physician Assistants graduated from Duke University Research revealed geographic maldistribution of primary care providers

More information

Appropriate Use: Big Brother is Watching. Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center

Appropriate Use: Big Brother is Watching. Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center Appropriate Use: Big Brother is Watching Jason H. Rogers, MD Director, Interventional Cardiology UC Davis Medical Center Disclosures Consultant Boston Scientific, Medtronic, Middle Peak Medical, Millipede,

More information

MicroRNA 126 predicts postoperative hyperglycemia

MicroRNA 126 predicts postoperative hyperglycemia MicroRNA 126 predicts postoperative hyperglycemia Fertouk Michal Z. 1, Benayoun Liat 1, Nanikashvili Azoulay Itzik 1, Adler Zvi 1, Eitan Abergel 2, Nir Rony Reuven 1, LeRoith Derek 3, Bitton Worms Keren

More information

Detection & Management of Retinal Emboli in a County Diabetes Retinal Screening Programme an audit

Detection & Management of Retinal Emboli in a County Diabetes Retinal Screening Programme an audit Detection & Management of Retinal Emboli in a County Diabetes Retinal Screening Programme an audit Prashant K Singh Specialist Registrar in Endocrinology, Diabetes & Internal Medicine The Royal Shrewsbury

More information

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs

The Role of Insurance in Providing Access to Cardiac Care in Maryland. Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs The Role of Insurance in Providing Access to Cardiac Care in Maryland Samuel L. Brown, Ph.D. University of Baltimore College of Public Affairs Heart Disease Heart Disease is the leading cause of death

More information

Treating Complex Valve Disease with World- Class Care

Treating Complex Valve Disease with World- Class Care Treating Complex Valve Disease with World- Class Care 2 When it comes to complex valve disease, Mission Heart is at the forefront of treatment innovation, performing more than 400 cardiac valve procedures

More information

L i D C O T M. Fluid management just got easier.

L i D C O T M. Fluid management just got easier. L i D C O T M Fluid management just got easier www.lidco.com Introducing the new Fluid and patient management made easier with the LiDCOrapid Monitor Fluid management just got easier The company that helped

More information

Peripheral Arterial Disease: Why You Should Care & How You Can Help. Jon Zlabek, MD, FACP Vascular Medicine

Peripheral Arterial Disease: Why You Should Care & How You Can Help. Jon Zlabek, MD, FACP Vascular Medicine Peripheral Arterial Disease: Why You Should Care & How You Can Help Jon Zlabek, MD, FACP Vascular Medicine jazlabek@gundluth.org Today s Objectives Review the assessment, diagnosis and treatment of peripheral

More information

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES

FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES FULL COVERAGE FOR PREVENTIVE MEDICATIONS AFTER MYOCARDIAL INFARCTION IMPACT ON RACIAL AND ETHNIC DISPARITIES Niteesh K. Choudhry, MD, PhD Harvard Medical School Division of Pharmacoepidemiology and Pharmacoeconomics

More information

Recurrent Stenosis in the SFA: Treatment Strategies

Recurrent Stenosis in the SFA: Treatment Strategies Recurrent Stenosis in the SFA: Treatment Strategies Darren B. Schneider, MD, FACS Disclosures W.L. Gore- research funding; speaker Cook, Inc.- research funding EV3 consultant Bard consultant Associate

More information

Vascular Surgery Rotation Goals & Objectives (Junior General Surgery Residents)

Vascular Surgery Rotation Goals & Objectives (Junior General Surgery Residents) Vascular Surgery Rotation Goals & Objectives (Junior General Surgery Residents) Overall Objectives Junior vascular surgery rotations are designed to provide vascular surgery residents with the cognitive,

More information

New Developments in the Surgical Treatment of Coronary Artery Disease. Harold A. Fernandez, MD

New Developments in the Surgical Treatment of Coronary Artery Disease. Harold A. Fernandez, MD New Developments in the Surgical Treatment of Coronary Artery Disease Harold A. Fernandez, MD Have there been any new developments in surgical treatment of coronary disease? Surgeon: He d had way too

More information

Non-surgical treatment of severe varicose veins

Non-surgical treatment of severe varicose veins Non-surgical treatment of severe varicose veins Yasu Harasaki UCHSC Department of Surgery General Surgery Grand Rounds March 19, 2007 Definition Dilated, palpable, subcutaneous veins generally >3mm in

More information

WENBIT Western Norway B-vitamin Intervention Trial

WENBIT Western Norway B-vitamin Intervention Trial WENBIT Western Norway B-vitamin Intervention Trial Marta Ebbing, MD Department of Heart Disease, Haukeland University Hospital, Bergen The WENBIT Study Group Background and Objectives Background Homocysteine-hypothesis

More information

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From the CoreValve US Pivotal Trial Steven J. Yakubov,

More information

January 2016, Volume: 8, Issue: 1, Pages: 1693-1700, DOI: http://dx.doi.org/10.19082/1693

January 2016, Volume: 8, Issue: 1, Pages: 1693-1700, DOI: http://dx.doi.org/10.19082/1693 Electronic Physician (ISSN: 2008-5842) http://www.ephysician.ir January 2016, Volume: 8, Issue: 1, Pages: 1693-1700, DOI: http://dx.doi.org/10.19082/1693 Clinicopathological comparisons of open vein harvesting

More information

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland CORONARY ARTERY BYPASS GRAFTS First performed

More information

Primary Prevention of Cardiovascular Disease with a Mediterranean diet

Primary Prevention of Cardiovascular Disease with a Mediterranean diet Primary Prevention of Cardiovascular Disease with a Mediterranean diet Alejandro Vicente Carrillo, Brynja Ingadottir, Anne Fältström, Evelyn Lundin, Micaela Tjäderborn GROUP 2 Background The traditional

More information

LEADERS: 5-Year Follow-up

LEADERS: 5-Year Follow-up LEADERS: -Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable Polymer : Final Report of the LEADERS

More information

Department of Pharmacy, Kaiser Permanente San Francisco Medical Center, San Francisco 94115, California, USA

Department of Pharmacy, Kaiser Permanente San Francisco Medical Center, San Francisco 94115, California, USA Journal of Pharmacy and Pharmacology 3 (2015) 33-38 doi: 10.17265/2328-2150/2015.01.005 D DAVID PUBLISHING Evaluation of Glycemic Control with a Pharmacist-Managed Post-Cardiothoracic Surgery Insulin Protocol

More information

Description of the OECD Health Care Quality Indicators as well as indicator-specific information

Description of the OECD Health Care Quality Indicators as well as indicator-specific information Appendix 1. Description of the OECD Health Care Quality Indicators as well as indicator-specific information The numbers after the indicator name refer to the report(s) by OECD and/or THL where the data

More information

CONTRAST. (COntrast media and NephroToxicity following coronary Revascularization by AngioplaSTy)

CONTRAST. (COntrast media and NephroToxicity following coronary Revascularization by AngioplaSTy) Randomized clinical trial to compare the nephrotoxic effects of iso osmolar vs. low osmolar contrast medium in patients with impaired renal function undergoing PCI CONTRAST (COntrast media and NephroToxicity

More information

Health Related Quality of Life and U.S. Economic Outcomes of PCI with Drug-Eluting Stents vs. Bypass Surgery: 1-Year Results from the SYNTAX Trial

Health Related Quality of Life and U.S. Economic Outcomes of PCI with Drug-Eluting Stents vs. Bypass Surgery: 1-Year Results from the SYNTAX Trial Health Related Quality of Life and U.S. Economic Outcomes of PCI with Drug-Eluting Stents vs. Bypass Surgery: 1-Year Results from the SYNTAX Trial David J. Cohen, Tara A. Lavelle, Patrick W. Serruys, Friedrich

More information

Section I. OPERATIVE. To correctly and consistently identify the surgeon. A drop down list is generated to avoid errors.

Section I. OPERATIVE. To correctly and consistently identify the surgeon. A drop down list is generated to avoid errors. Section I. OPERATIVE Section Intent: The primary intent of this section is to have a clear picture of the patient s clinical status upon entering the operating room with regard to 1) Clinical status; 2)

More information

Preoperative tests. National Clinical Guideline Centre. Routine preoperative tests for elective surgery. Clinical guideline <...

Preoperative tests. National Clinical Guideline Centre. Routine preoperative tests for elective surgery. Clinical guideline <... National Clinical Guideline Centre Draft for consultation Preoperative tests Routine preoperative tests for elective surgery Clinical guideline Appendix N: Research recommendations October 2015 Draft

More information

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone

Cardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest

More information

Statement before the Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee

Statement before the Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee The Society of Thoracic Surgeons (STS) Statement before the Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee July 20, 2011 The Society of Thoracic

More information

Evidence tabel Lokaal palliatieve behandelingen

Evidence tabel Lokaal palliatieve behandelingen Auteurs, jaartal Mate van bewijs Studie type Follow-up Populatie (incl. steekproef-grootte) Patienten kenmerken Interventie Controle Resultaten Conclusie Opmerkingen, commentaar Hartgrink, 2002 The Netherlands

More information

Disclosures Funded by VHA HSR&D Investigator Initiated Award (IIR ) Dr. Bosworth was supported by a VHA HSR&D Senior Scientist Award (08-027) Dr

Disclosures Funded by VHA HSR&D Investigator Initiated Award (IIR ) Dr. Bosworth was supported by a VHA HSR&D Senior Scientist Award (08-027) Dr Multifaceted Intervention to Improve Medication Adherence and Secondary Prevention Measures (Medication Study) After Acute Coronary Syndrome Hospital Discharge Ho PM, Lambert-Kerzner A, Carey EP, Fahdi

More information

Coronary Artery Bypass Graft and/or Valve Surgery PROCEDURAL CONSENT FORM. A. Interpreter / cultural needs. B. Condition and treatment

Coronary Artery Bypass Graft and/or Valve Surgery PROCEDURAL CONSENT FORM. A. Interpreter / cultural needs. B. Condition and treatment v2.00 02/2011 A. Interpreter / cultural needs An Interpreter Service is required? Yes No If Yes, is a qualified Interpreter present? Yes No A Cultural Support Person is required? Yes No If Yes, is a Cultural

More information

50 TOP CARDIOVASCU 50 TOP CARDIOVASCULAR HOSPITALS, 2014 A NATIONAL BENCHMARKS REPORT

50 TOP CARDIOVASCU 50 TOP CARDIOVASCULAR HOSPITALS, 2014 A NATIONAL BENCHMARKS REPORT 50 TOP CARDIOVASCU 50 TOP CARDIOVASCULAR HOSPITALS, 2014 A NATIONAL BENCHMARKS REPORT Performance Report Prepared For: Sample MEDICARE ID: 999999 50 TOP CARDIOVASCULAR HOSPITALS, 2014 Sample REPORT NOTES

More information

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma

Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Accelerated hemithoracic radiation followed by extrapleural pneumonectomy for malignant pleural mesothelioma Marc de Perrot, Ronald Feld, Natasha B Leighl, Andrew Hope, Thomas K Waddell, Shaf Keshavjee,

More information

PCI vs. CABG for Left Main Disease

PCI vs. CABG for Left Main Disease The EXCEL Ti Trial Design, Status, t and Timelines Gregg W. Stone, MD Columbia University Medical Center NewYork-Presbyterian Hospital Cardiovascular Research Foundation PCI vs. CABG for Left Main Disease

More information

Clinical characteristics & impact of Peripheral Vascular Disease in Diabetes. Keimyung University Hye Soon Kim

Clinical characteristics & impact of Peripheral Vascular Disease in Diabetes. Keimyung University Hye Soon Kim Clinical characteristics & impact of Peripheral Vascular Disease in Diabetes Keimyung University Hye Soon Kim Peripheral Vascular Disease Diseases to arteries & veins outside thoracic region Main cause

More information